Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics Inc. on the transaction. Denali Therapeutics (Nasdaq: DNLI) announced that it entered into a securities purchase agreement with...
You must be a Standard 1 Year member to access this content.
Sidley advised Denali Capital Acquisition Corp., while Nelson Mullins Riley & Scarborough LLP assisted Longevity Biomedical. US Tiger Securities acted as business combination advisor to Denali. Denali...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
